The PE Ratio as of June 2026 (TTM) for Cogent Biosciences, Inc. (COGT) is -15.25

According to Cogent Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -15.25. This represents a change of 199.13% compared to the average of -5.10 of the last 4 quarters.

Cogent Biosciences, Inc. (COGT) Historical PE Ratio (quarterly & annually)

How has COGT PE Ratio performed in the past?

The mean historical PE Ratio of Cogent Biosciences, Inc. over the last ten years is -5.52. The current -15.25 PE Ratio has changed 27.55% with respect to the historical average. Over the past ten years (40 quarters), COGT's PE Ratio was at its highest in in the December 2019 quarter at 2.40. The PE Ratio was at its lowest in in the September 2015 quarter at -14.78.

Cogent Biosciences, Inc. (COGT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cogent Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cogent Biosciences, Inc. (COGT) Average PE Ratio

How has COGT PE Ratio performed in the past?

The current PE Ratio of Cogent Biosciences, Inc. (COGT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cogent Biosciences, Inc. (COGT) PE Ratio vs. Peers

How is COGT’s PE Ratio compared to its peers?

Cogent Biosciences, Inc.’s PE Ratio is less than Arcus Biosciences, Inc. (-8.09), less than ImmunityBio, Inc. (-8.53), less than Denali Therapeutics Inc. (-7.96), less than 89bio, Inc. (-7.78), less than Galapagos N.V. (3.36), less than Liquidia Corporation (281.04), less than Ocular Therapeutix, Inc. (-6.90), less than Agios Pharmaceuticals, Inc. (-4.10), less than Viridian Therapeutics, Inc. (-4.63), less than Recursion Pharmaceuticals, Inc. (-2.98),

Build a custom stock screener for Cogent Biosciences, Inc. (COGT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cogent Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cogent Biosciences, Inc. (COGT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cogent Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.